Study Of Thrombotic Thrombocytopenic Purpura Medicine Demonstrates Safety
Caplacizumab is a medicine that has been developed to treat acquired thrombotic thrombocytopenic purpura (TTP). TTP causes serious symptoms. such as thrombocytopenia, a condition in which a patient doesn't have enough platelets. A…